Press Releases

Logical Biological and Bcell Design Announce Strategic Partnership for Engineered Disease State Materials

Logical Biological, biospecimen and critical raw material leader, and Bcell Design, pioneers in transgenic monoclonal antibody technology, today announced a long term strategic partnership to deliver engineered disease state materials for diagnostic and research markets.

Precision BioLogic Leads the Way in Hemophilia Testing: Proven CRYOcheck™ Chromogenic Factor VIII assay now offers expanded utility in anticipation of emerging treatments

Precision BioLogic Inc., a leading developer of hemostasis diagnostic products, is pleased to announce the expanded utility of its CRYOcheck Chromogenic Factor VIII assay in anticipation of emerging hemophilia treatments such as Mim8, a next generation bispecific antibody for the treatment of hemophilia A. The updated assay will ensure labs are ready and able to deliver accurate results when new treatments become available.

Proscia Unveils Aperture, Making the Moment of Diagnosis the Gateway to Life-Saving Treatments for More Patients

For participating academic medical centers, healthcare systems, and reference laboratories, Proscia Aperture elevates pathology from a diagnostic function to a strategic revenue driver.

UMass Signed a Non-Exclusive License Agreement with Hongene

UMass Chan Medical School has signed a non-exclusive license agreement with Hongene Biotech to produce exNA-modified oligonucleotides, a breakthrough in RNA therapeutics that improves drug stability and opens new doors for advanced research.

Abselion Launches AAVX and AAV9 Total Capsid Quantification Kits

• Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes • Kits incorporate Thermo Fisher Scientific’s CaptureSelect affinity reagents for enhanced specificity and consistency

Gifthealth + Occam Health: Transforming Patient Access at Scale

Gifthealth today announced its acquisition of Occam Health Services creating the first-of-its-kind digital pharmacy platform and patient access hub solution fundamentally shifting how biopharma companies accelerate access and value for patients.

One2Treat raises capital to further accelerate software platform development and relocates offices to support rapid growth

One2Treat SA, a fast-growing technology company transforming how the patient voice is integrated into clinical development, announced today the successful completion of a planned seed extension to accelerate its software platform development.

Onvida Health and Ambience Healthcare Launch Frontier Ambient AI Capabilities Inside Epic

EpiCypher Launches Fiber-seq, a Breakthrough Multiomic Single-Molecule Genomics Assay

Aptamer Group Introduces Novel Biomarker Discovery Service

DNAnexus Enhances Leadership to Fuel AI Innovation and Biopharma Expansion

Company appoints Pieter De Leenheer as Chief Technology Officer and Todd Oakland as Senior Vice President and General Manager of Biopharma Business Dx/Rx

Baylor Genetics to Showcase RNA Sequencing Breakthroughs for Rare Disease Diagnosis at 2025 AGBT Precision Health Meeting

Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced its participation in the 2025 Advances in Genome Biology and Technology (AGBT) Precision Health Conference, taking place September 8–10, 2025, in San Diego, CA. The company will present important data underscoring the clinical utility of RNA sequencing in the diagnosis of rare and previously undiagnosed diseases.

eClinical Solutions Announces Integrated Data Review Plan (IDRP) Capabilities Within elluminate Platform

Company becomes the first to centralize digital data review activities within a single platform as the industry focuses on clinical trial efficiency

Global healthcare AI experts and former UK Health Minister back AI that detects healthcare-associated infections up to 72 hours earlier

Ambience Healthcare Joins Epic Toolbox, Unlocking Advanced AI Functionality Within Haiku for Epic Customers

Baylor Genetics Hosts Webinar Highlighting the Power of Whole Genome Sequencing in Complex Pediatric Cases

Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced a clinical webinar highlighting pediatric cases in which Whole Genome Sequencing (WGS) delivered diagnostic insights that traditional genetic testing methods could not achieve.

Firstsource and Guidehealth Partner to Accelerate AI-Enabled Value-Based Care Innovation for Health Plans

VieCure Expands Community Oncology Care Network with Addition of Summit Cancer Centers

VieCure adds Summit Cancer Centers to community oncology care network

Kaleo’s AUVI-Q® (epinephrine injection, USP) Selected by Axiom Space to Help Protect Crew from Allergic Emergencies

The Axiom Space Mission 4 (Ax-4) launched from NASA’s Kennedy Space Center, and for the first time, Kaléo’s AUVI-Q® (epinephrine injection, USP) was selected by Axiom Space to support crew members in the event of an allergic emergency. Axiom Space additionally cleared AUVI-Q for inclusion on its flight surgeons’ launch and landing kits used to support the crew in the weeks leading up to launch and later during landing. Read more about the Axiom Space Mission 4: Kaleo press release Kaléo was founded 20 years ago with a mission to develop drug-delivery devices that can be trusted by those who depend on them. All medications added to the Space Mission 4 medical kit undergo rigorous review by Axiom Space. Being trusted by Axiom Space to ensure the Ax-4 Mission crew had access to a trusted epinephrine delivery device is the ultimate responsibility.

Clearwater Launches New Enterprise Cyber Risk Management Solution to Help Healthcare Organizations Reduce Cyber Risk, Strengthen Compliance, and Drive Boardroom Confidence